Acquisition by Edward Kangas of 4682 shares of Tenet Healthcare subject to Rule 16b-3

THC
 Stock
  

USD 53.05  0.17  0.32%   

Filed transaction by Tenet Healthcare Corp director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Published over a year ago
View all stories for Tenet Healthcare | View All Stories
Transaction by Edward Kangas

How important is Tenet Healthcare's Liquidity

Tenet Healthcare financial leverage refers to using borrowed capital as a funding source to finance Tenet Healthcare Corp ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Tenet Healthcare financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Tenet Healthcare's total debt and its cash.

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions.
It is good to see analyst projects for Tenet Healthcare, but it might be worth checking our own buy vs. sell analysis

Sale by J Kerrey of 9278 shares of Tenet Healthcare

Legal trades by Tenet Healthcare insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Tenet insider trading alert for sale of common stock by J Kerrey, the corporate stakeholder, on 12th of August 2022. This event was filed by Tenet Healthcare Corp with SEC on 2022-08-12. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

What is the case for Tenet Healthcare Investors

Tenet Healthcare Corporation insider trading alert for grant of 2013 may director stock units by Edward Kangas, the corporate stakeholder, on September 1, 2019. This event was filed by Tenet Healthcare Corp with SEC on 2013-05-08. Statement of changes in beneficial ownership - SEC Form 4. Edward Kangas is currently serves as independent chairman of the board of Tenet Healthcare